Anu’s Lab Plans to Invest 250 Crore Rupees For Expansion

Table of Contents

Anu’s Laboratories Ltd, manufacturer of bulk drug intermediates, plans to invest Rs 250 crore for further expansion, acquisition, Mr Hari Babu, Managing Director, Anu’s Labs told mediapersons here on Thursday.

The company is in manufacturing of bulk drug intermediates for the last 13 years and having leadership in most of its products being manufactured namely i.e 2,4-Dichloro-5 Fluoro Acetophenone and other high quality intermediates such as Chlorohexanone, 1 ,3-Dibromo Propane, Methy1-4 (4-Chloro 1 oxo butyl), Di-Methyl Acetate etc., Mr Hari Babu said.

The company has been working on various new processes taking advantage of its edge on process development, exploring the new export markets including regulatory markets with the coming up of new FDA plant at Vizag with an outlay of Rs 63 crore and expand ing the capacities in existing units and at other places including other states, Mr Hari Babu added. – PTI

Share the Post:
Facebook
Twitter
LinkedIn

Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.

OPEN DEMAT ACCOUNT